{"id":"silver-sulfadiazine-cream-1","safety":{"commonSideEffects":[{"rate":"null","effect":"Skin irritation"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Silver sulfadiazine works by releasing silver ions, which have broad-spectrum antibacterial activity against both Gram-positive and Gram-negative bacteria. This helps to prevent the growth of bacteria in wounds and burns, reducing the risk of infection.","oneSentence":"Silver sulfadiazine cream acts as a topical antibacterial agent, inhibiting bacterial growth and preventing infection in burns and wounds.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:34:42.756Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of wound and burn infections"}]},"trialDetails":[{"nctId":"NCT01297400","phase":"PHASE2","title":"Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns","status":"RECRUITING","sponsor":"Skingenix, Inc.","startDate":"2022-03-11","conditions":"Burns","enrollment":60},{"nctId":"NCT05877638","phase":"NA","title":"SWC for Treatment of Superficial Partial-Thickness Burns","status":"TERMINATED","sponsor":"Synedgen, Inc.","startDate":"2023-03-27","conditions":"Burn Wounds","enrollment":2},{"nctId":"NCT04936204","phase":"NA","title":"Clinical Investigation to Evaluate the Safety and Performance of ConnettivinaBio Plus Cream Compared to ConnettivinaBio Cream in the Management of Wounds in Patients at High Risk of Infection","status":"UNKNOWN","sponsor":"Fidia Farmaceutici s.p.a.","startDate":"2021-06-10","conditions":"Wounds","enrollment":80},{"nctId":"NCT02108535","phase":"PHASE4","title":"Comparative Analysis of Cost-effectiveness of Silver Dressing in Burns","status":"COMPLETED","sponsor":"University of Sorocaba","startDate":"2013-11","conditions":"Second-degree Burn","enrollment":100},{"nctId":"NCT04391582","phase":"PHASE2","title":"Pediatric Burn Treatment Using Tilapia Skin as a Xenograft for Superficial-Partial Thickness Wounds","status":"COMPLETED","sponsor":"Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara","startDate":"2017-05-01","conditions":"Burns","enrollment":30},{"nctId":"NCT04202289","phase":"PHASE3","title":"Use of Nile Tilapia Fish Skin as a Xenograft for Burn Treatment: Phase III Study","status":"COMPLETED","sponsor":"Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara","startDate":"2017-04-03","conditions":"Burns","enrollment":115},{"nctId":"NCT03574935","phase":"PHASE2","title":"Clinical Evaluation and Generalized Application of \"Qing-Hua-Bu\" Three Dynamic Sequential Therapy of Diabetic Ulcer","status":"UNKNOWN","sponsor":"Shanghai Yueyang Integrated Medicine Hospital","startDate":"2018-07-01","conditions":"Diabetic Foot, Ulcer, Skin","enrollment":150},{"nctId":"NCT01439074","phase":"NA","title":"Mepilex Ag Versus Silver Sulfadiazine in Children and Adults With Burn Injuries.","status":"COMPLETED","sponsor":"Molnlycke Health Care AB","startDate":"2011-09","conditions":"Burn Injuries","enrollment":162},{"nctId":"NCT00742183","phase":"NA","title":"Evaluating the Cost-effectiveness, Efficacy, Safety and Tolerance of Mepilex® Ag Versus Silvadene®","status":"COMPLETED","sponsor":"Molnlycke Health Care AB","startDate":"2008-08","conditions":"Second Degree Burn","enrollment":100},{"nctId":"NCT00332163","phase":"PHASE2","title":"Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy","status":"COMPLETED","sponsor":"Amgen","startDate":"2006-04","conditions":"Metastatic Colorectal Cancer, Skin Rash, Skin Toxicities","enrollment":95},{"nctId":"NCT02497326","phase":"NA","title":"Heparin for the Treatment of Burn Wound Pain","status":"UNKNOWN","sponsor":"King Edward Medical University","startDate":"2015-04","conditions":"Second Degree Burns","enrollment":36},{"nctId":"NCT01701466","phase":"PHASE2","title":"Neoviderm Skin Emulsion in the Prevention of Radiation Dermatitis","status":"TERMINATED","sponsor":"Sir Mortimer B. Davis - Jewish General Hospital","startDate":"2011-12","conditions":"Head and Neck Cancer, Breast Cancer","enrollment":14},{"nctId":"NCT02109718","phase":"PHASE3","title":"A Trial Comparing the Efficacy and Safety of Open Dressing With Petrolatum Jelly vs. Standard Gauze Dressing With Silver Sulfadiazine","status":"COMPLETED","sponsor":"University of the Philippines","startDate":"2009-01","conditions":"Superficial Partial Thickness Burns","enrollment":50},{"nctId":"NCT00860717","phase":"NA","title":"The Use of Low Level Laser Therapy for Wound Healing in Leprosy Patients","status":"COMPLETED","sponsor":"Para Federal University","startDate":"2006-11","conditions":"Leprosy","enrollment":25}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Silver Sulfadiazine"],"phase":"phase_3","status":"active","brandName":"Silver Sulfadiazine Cream 1%","genericName":"Silver Sulfadiazine Cream 1%","companyName":"Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara","companyId":"nucleo-de-pesquisa-e-desenvolvimento-de-medicamentos-da-universidade-federal-do","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Silver sulfadiazine cream acts as a topical antibacterial agent, inhibiting bacterial growth and preventing infection in burns and wounds. Used for Prevention of wound and burn infections.","enrichmentLevel":3,"visitCount":2,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}